Thermo Fisher Scientific Inc.

BUL:TN8 Voorraadrapport

Marktkapitalisatie: €205.3b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Thermo Fisher Scientific Toekomstige groei

Future criteriumcontroles 1/6

Thermo Fisher Scientific is forecast to grow earnings and revenue by 10.6% and 5.6% per annum respectively. EPS is expected to grow by 11% per annum. Return on equity is forecast to be 17.5% in 3 years.

Belangrijke informatie

10.6%

Groei van de winst

11.0%

Groei van de winst per aandeel

Life Sciences winstgroei0%
Inkomstengroei5.6%
Toekomstig rendement op eigen vermogen17.5%
Dekking van analisten

Good

Laatst bijgewerkt06 Aug 2024

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

BUL:TN8 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202649,0938,0399,47610,64120
12/31/202545,7416,9258,6439,49525
12/31/202442,9556,1426,8398,00925
6/29/202442,3466,2207,9639,348N/A
3/30/202442,4926,0347,5608,928N/A
12/31/202342,8575,9956,9278,406N/A
9/30/202343,4215,9416,5468,170N/A
7/1/202343,5245,7215,8547,693N/A
4/1/202343,8076,0245,6207,681N/A
12/31/202244,9156,9506,9119,154N/A
10/1/202244,1677,0325,6008,124N/A
7/2/202242,8207,4396,3368,837N/A
4/2/202241,1237,6037,0019,536N/A
12/31/202139,2117,7256,7899,312N/A
10/2/202139,0598,5657,91610,194N/A
7/3/202138,2508,5968,13210,252N/A
4/3/202135,8947,9248,0629,911N/A
12/31/202032,2186,3756,8158,289N/A
9/26/202028,4974,8795,6866,863N/A
6/27/202026,2483,7064,2455,272N/A
3/28/202025,6473,6693,7024,680N/A
12/31/201925,5423,6964,0474,973N/A
9/28/201925,2203,5923,9404,861N/A
6/29/201924,8683,5414,0864,964N/A
3/30/201924,6303,1744,2735,114N/A
12/31/201824,3582,9383,7854,543N/A
9/29/201823,8982,5703,9194,608N/A
6/30/201823,0942,3953,6894,317N/A
3/31/201822,0062,256N/A3,722N/A
12/31/201720,9182,228N/A4,005N/A
9/30/201719,8242,330N/A3,344N/A
7/1/201719,1992,270N/A3,220N/A
4/1/201718,7442,174N/A3,284N/A
12/31/201618,2742,025N/A3,258N/A
10/1/201617,9731,999N/A3,281N/A
7/2/201617,6062,003N/A3,220N/A
4/2/201617,3411,998N/A3,072N/A
12/31/201516,9651,980N/A2,942N/A
9/26/201516,8061,978N/A2,543N/A
6/27/201516,8541,971N/A2,475N/A
3/28/201516,9051,738N/A2,598N/A
12/31/201416,8901,896N/A2,620N/A
9/27/201415,8641,635N/A2,394N/A
6/28/201414,8841,482N/A2,224N/A
3/29/201413,8021,481N/A1,814N/A
12/31/201313,0901,279N/A2,011N/A
9/28/201312,8831,322N/A1,942N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: TN8's forecast earnings growth (10.6% per year) is above the savings rate (3%).

Winst versus markt: TN8's earnings (10.6% per year) are forecast to grow slower than the BG market (13.5% per year).

Hoge groeiwinsten: TN8's earnings are forecast to grow, but not significantly.

Omzet versus markt: TN8's revenue (5.6% per year) is forecast to grow slower than the BG market (24.5% per year).

Hoge groei-inkomsten: TN8's revenue (5.6% per year) is forecast to grow slower than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: TN8's Return on Equity is forecast to be low in 3 years time (17.5%).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y